Rapid cognitive screening of patients with substance use disorders.
- 1 January 2009
- journal article
- Published by American Psychological Association (APA) in Experimental and Clinical Psychopharmacology
- Vol. 17 (5), 337-344
- https://doi.org/10.1037/a0017260
Abstract
To date, there has not been a time-efficient and resource-conscious way to identify cognitive impairment in patients with substance use disorders (SUDs). In this study, we assessed the validity, accuracy, and clinical utility of a brief (10-min) screening instrument, the Montreal Cognitive Assessment (MoCA), in identifying cognitive impairment among patients with SUDs. The Neuropsychological Assessment Battery-Screening Module, a 45-min battery with known sensitivity to the mild to moderate deficits observed in patients with SUDs, was used as the reference criterion for determining agreement, rates of correct and incorrect decision classifications, and criterion-related validity for the MoCA. Classification accuracy of the MoCA, based on receiver operating characteristic (ROC) analysis, was strong, with an area under the ROC curve of 0.86, 95% confidence interval [0.75, 0.97]. The MoCA also showed acceptable sensitivity (83.3%) and specificity (72.9%) for the identification of cognitive impairment. Using a cutoff of 25 on the MoCA, the overall agreement was 75.0%; chance-corrected agreement (kappa) was 41.9%. These findings indicate that the MoCA provides a time-efficient and resource-conscious way to identify patients with SUDs and neuropsychological impairment, thus addressing a critical need in the addiction treatment research community.Keywords
Funding Information
- National Institute on Drug Abuse (1 R03 DA024126-01, 5K24DA022288-02)
This publication has 49 references indexed in Scilit:
- An Item Response Theory Modeling of Alcohol and Marijuana Dependences: A National Drug Abuse Treatment Clinical Trials Network StudyJournal of Studies on Alcohol and Drugs, 2009
- Memory, executive cognitive function, and readiness to change drinking behaviorAddictive Behaviors, 2005
- Assessment practices of clinical neuropsychologists in the United States and Canada: A survey of INS, NAN, and APA Division 40 membersArchives of Clinical Neuropsychology, 2005
- Cognitive Functioning of Long-term Heavy Cannabis Users Seeking TreatmentJAMA, 2002
- Cannabis, cognition, and residual confounding.JAMA, 2002
- Addiction Denial and Cognitive DysfunctionThe Journal of Neuropsychiatry and Clinical Neurosciences, 2002
- Residual neuropsychologic effects of cannabisCurrent Psychiatry Reports, 2001
- Effects of Acute Smoked Marijuana on Complex Cognitive PerformanceNeuropsychopharmacology, 2001
- Self-report and objective measures of cognitive deficit in patients entering substance abuse treatmentPsychiatry Research, 1999
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960